OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression
Philip Borsellino, Reese I. Krider, Deanna Chea, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 742-742
Open Access | Times Cited: 13
Philip Borsellino, Reese I. Krider, Deanna Chea, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 742-742
Open Access | Times Cited: 13
Showing 13 citing articles:
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach
Phil Wolfson, Gita Vaid
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Phil Wolfson, Gita Vaid
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Enhancing proteasome activity by NMDAR antagonists explains their therapeutic effect in neurodegenerative and mental diseases
Fikret Şahin, Aslıhan Günel, Buse Türegün Atasoy, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Fikret Şahin, Aslıhan Günel, Buse Türegün Atasoy, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor
John E. Donello, Roger S. McIntyre, Donald B. Pickel, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 157-157
Open Access
John E. Donello, Roger S. McIntyre, Donald B. Pickel, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 157-157
Open Access
Brain region–specific roles of brain-derived neurotrophic factor in social stress–induced depressive-like behavior
Man Yong Han, Deyang Zeng, Wei Tan, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 159-173
Open Access | Times Cited: 4
Man Yong Han, Deyang Zeng, Wei Tan, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 159-173
Open Access | Times Cited: 4
Molecular Regulation and Therapeutic Applications of Brain-Derived Neurotrophic Factor–Tropomyosin-Related Kinase B Signaling in Major Depressive Disorder Though Its Interaction with Vascular Endothelial Growth Factor and N-Methyl-D-Aspartic Acid Receptors: A Narrative Review
Yasunari Matsuzaka, Ryu Yashiro
Biologics (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Yasunari Matsuzaka, Ryu Yashiro
Biologics (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Molecular and Medical Aspects of Psychedelics
Adam Wojtas, Krystyna Gołembiowska
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 241-241
Open Access | Times Cited: 8
Adam Wojtas, Krystyna Gołembiowska
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 241-241
Open Access | Times Cited: 8
Ketamine’s Amelioration of Fear Extinction in Adolescent Male Mice Is Associated with the Activation of the Hippocampal Akt-mTOR-GluA1 Pathway
Emilija Glavonic, Milorad Dragić, Miloš Mitić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 669-669
Open Access | Times Cited: 2
Emilija Glavonic, Milorad Dragić, Miloš Mitić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 669-669
Open Access | Times Cited: 2
Activation of σ1-Receptors by R-Ketamine May Enhance the Antidepressant Effect of S-Ketamine
Hans O. Kalkman
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2664-2664
Open Access | Times Cited: 5
Hans O. Kalkman
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2664-2664
Open Access | Times Cited: 5
Interplay of G-proteins and Serotonin in the Neuroimmunoinflammatory Model of Chronic Stress and Depression: A Narrative Review
Evgeni Gusev, Alexey Sarapultsev
Current Pharmaceutical Design (2023) Vol. 30, Iss. 3, pp. 180-214
Closed Access | Times Cited: 5
Evgeni Gusev, Alexey Sarapultsev
Current Pharmaceutical Design (2023) Vol. 30, Iss. 3, pp. 180-214
Closed Access | Times Cited: 5
Depression, an unmet health need in Africa: Understanding the promise of ketamine
Aletta ME. Millen, Willie M. U. Daniels, Sooraj Baijnath
Heliyon (2024) Vol. 10, Iss. 7, pp. e28610-e28610
Open Access | Times Cited: 1
Aletta ME. Millen, Willie M. U. Daniels, Sooraj Baijnath
Heliyon (2024) Vol. 10, Iss. 7, pp. e28610-e28610
Open Access | Times Cited: 1
Optimizing esketamine administration for postoperative depression: a comprehensive study on laparoscopic bariatric surgery patients
Jiabao Dai, Yanfeng Lü, Zhiqing Zou, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 1
Jiabao Dai, Yanfeng Lü, Zhiqing Zou, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 1
Acute stress induces different changes on the expression of CB1 receptors in the hippocampus of two lines of male rats differing in their response to stressors
Maria Pina Serra, Marianna Boi, Ylenia Lai, et al.
Pharmacology Biochemistry and Behavior (2024), pp. 173901-173901
Open Access
Maria Pina Serra, Marianna Boi, Ylenia Lai, et al.
Pharmacology Biochemistry and Behavior (2024), pp. 173901-173901
Open Access
Microglia stimulation produces antidepressant-like effects in a mouse depression model induced by adolescent chronic unpredictable stress
Hanxiao Wang, Jie Peng, Hao‐Jie Zhu, et al.
Physiology & Behavior (2024) Vol. 291, pp. 114782-114782
Closed Access
Hanxiao Wang, Jie Peng, Hao‐Jie Zhu, et al.
Physiology & Behavior (2024) Vol. 291, pp. 114782-114782
Closed Access
